Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial

Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible on the page.
    Difference
    1%
    Check dated 2026-10-25T06:34:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the study page remains an error page.
    Difference
    0.2%
    Check dated 2026-10-18T06:45:34.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:41:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study page continues to display a 403 Forbidden error instead of study information.
    Difference
    0.2%
    Check dated 2026-10-04T08:49:04.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with minimal HTML, replacing the previous detailed study content and locations.
    Difference
    17%
    Check dated 2026-09-20T03:46:49.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    NIH grant/contract funding information (2017) was added to the study's identifiers, clarifying funding and registry references. The page's revision label was updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T23:41:53.000Z thumbnail image

Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.